Join Brian Smith, VP, Operations, ERT as he presents, “Optimizing ECG Collection in Phase 1 Studies,” at ExL Events’ Clinical Trials Phase I & IIA Summit this October. He’ll share insights to help trial leaders confidently navigate unexpected issues in early-phase trials — from study start to close-out, including:
- Understanding regulatory changes and how to adjust your study design
- Avoiding common mistakes in protocol design for ECG collection
- Implementing practical solutions to ECG data collection challenges in Phase 1 Oncology studies
- Getting the most out of your Phase 1 study for ECG endpoints and potential TQT waivers
Can’t make it to the meeting, but want to learn how ERT can support your upcoming cardiac safety study? Click here to learn more.